Allergan Must Face FCA Suit Over Drug Samples, Rx Pads

Law360, New York (April 3, 2017, 8:15 PM EDT) -- A New York federal judge largely upheld a whistleblower’s False Claims Act suit accusing Allergan Inc. of bribing doctors to prescribe eye care products by providing drug samples and prescription pads, and then wrongly firing the former employee, dismissing only some state claims.

In an 89-page ruling, U.S. District Judge Jesse M. Furman said the suit wasn’t barred by the FCA's public disclosure or first-to-file bar, even though similar litigation had been brought before, and said the suit meets the FCA’s standards. John Wood filed the...
To view the full article, register now.